UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon
|
2019-03-07 15:10
라인
Celltrion Healthcare wins biosimilar bids in SE Asia
Celltrion Healthcare said that it won the bids for Singapore’s infliximab b...
by Lee Han-soo
|
2019-03-07 14:25
라인
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo
|
2019-03-07 14:25
라인
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im
|
2019-03-07 11:54
라인
SNUBH implements smart surgical system
Seoul National University Bundang Hospital (SNUBH) said that it has built a...
by Lee Han-soo
|
2019-03-06 17:37
라인
Foreign patients mostly satisfied with Korea’s healthcare service
International patients who received treatment at Korean medical institution...
by Lee Han-soo
|
2019-03-06 17:05
라인
Interagency new drug development project generates ₩7.3 trillion license deals
The government said the “pan-governmental full-cycle new drug development p...
by Kwak Sung-sun
|
2019-03-06 16:24
라인
EzCareTech to speed up global presence with IPO
EzCareTech expressed its aspiration to become a global health networking le...
by Lee Han-soo
|
2019-03-06 14:58
라인
Biogen seeks gene therapy pipeline for rare eye disease
The biotech industry is paying attention to whether Biogen’s recent acquisi...
by Kim Yun-mi
|
2019-03-06 14:41
라인
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate
Genexine said Monday that I-Mab Biopharma, a Chinese bio-firm, has administ...
by Lee Han-soo
|
2019-03-06 14:27
라인
Binex, Chongqing Zein to establish joint company
Binex said Wednesday that it has signed an agreement to establish a joint-v...
by Lee Han-soo
|
2019-03-06 13:41
라인
Korea to crack down on illegal drugs amid ‘Burning Sun’ scandal
Nine government agencies have set about to crack down on the distribution o...
by Lee Hye-seon
|
2019-03-06 12:27
라인
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer
Samsung Bioepis said Tuesday that the European Medicines Agency has granted...
by Lee Han-soo
|
2019-03-05 17:53
라인
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin
Medytox continued Tuesday to pressure Daewoong Pharmaceuticals to clarify s...
by Lee Han-soo
|
2019-03-05 16:22
라인
Jeju Province to nullify approval for for-profit hospital
China’s Greenland Group requested Jeju Province to extend the deadline for ...
by Lee Min-ju
|
2019-03-05 16:22
라인
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status
The Ministry of Food and Drug Safety has granted Hanmi’s HM43239, a treatme...
by Lee Han-soo
|
2019-03-05 15:34
라인
Handok to market Amicus Therapeutics’ Fabry disease treatment
Handok said Tuesday that it has signed a local sales agreement with Amicus ...
by Lee Han-soo
|
2019-03-05 15:11
라인
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment
Lilly Korea is to conduct a clinical trial on rheumatoid arthritis drug Olu...
by Lee Hye-seon
|
2019-03-05 15:10
라인
3rd-generation antiepileptic drug lands on Korea
Briviact(ingredient: brivaracetam), a third-generation antiepileptic treatm...
by Lee Hye-seon
|
2019-03-05 14:42
라인
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa
The International Vaccine Institute (IVI) said it has received a $3.2 milli...
by Lee Han-soo
|
2019-03-05 14:41
-
이전
141
142
143
144
145
146
147
148
149
150
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top